Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
Use this MCRB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MCRB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MCRB SEC filings page. Lician reads the product cache first so this HTML stays unique to Seres Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MCRB income, balance, and cash tables.